AVE 25.0% 0.3¢ avecho biotechnology limited

once a week insulin drug, page-12

  1. 564 Posts.
    lightbulb Created with Sketch. 1
    Just to clarify KC, the new drug is a rejigged version of Byetta. A company called Alkermes is developing the technology to keep the drug in the body for a week. A number of big pharma are also working on the same drug.

    http://www.cnbc.com/id/15840232?play=1&video=1435759502
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.